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Named entity (NE) recognition is a fundamental task in biological relationship mining. This paper considers protein/gene col-
locates extracted from biological corpora as restrictions to enhance the precision rate of protein/gene name recognition. In addition,
we integrate the results of multiple NE recognizers to improve the recall rates. Yapex and KeX, and ABGene and Idgene are taken
as examples of protein and gene name recognizers, respectively. The precision of Yapex increases from 70.90 to 85.84% at the low
expense of the recall rate (i.e., it only decreases 2.44%) when collocates are incorporated. When both ﬁltering and integration strat-
egies are employed together, the Yapex-based integration with KeX shows good performance, i.e., the F-score increases by 7.83%
compared to the pure Yapex method. The results of gene recognition show the same tendency. The ABGene-based integration with
Idgene shows a 10.18% F-score increase compared to the pure ABGene method. These successful methodologies can be easily
extended to other name ﬁnders in biological documents.
 2004 Elsevier Inc. All rights reserved.
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Named entities are basic constituents in a document
and recognizing them is a fundamental step for docu-
ment understanding. In the message understanding com-
petition MUC [1], named entity extraction was one of
the evaluation tasks. The named entities included orga-
nizations, people, locations, date/time expressions, mon-
etary expressions, and percentage expressions. Several
approaches have been proposed to capture these types
of terms. For example, corpus-based methods are em-
ployed to extract Chinese personal names, and rule-
based methods are used to extract Chinese date/time
expressions as well as monetary and percentage expres-
sions [2,3]. The corpus-based approach is adopted1532-0464/$ - see front matter  2004 Elsevier Inc. All rights reserved.
doi:10.1016/j.jbi.2004.08.006
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hh_chen@csie.ntu.edu.tw (H.-H. Chen).because a large personal name database is available
for training. In contrast, rules that have good coverage
exist for date/time expressions, so that the rule-based ap-
proach is adopted.
In the past, named entity extraction has mainly fo-
cused on general domains. However, many scientiﬁc
documents have been published recently, especially in
the biomedical domain. Several attempts have been
made to mine knowledge from biomedical documents
[4], such as identifying protein/gene names, recognizing
protein interactions, and capturing speciﬁc relations in
databases. One of the goals is to construct a knowledge
base automatically and ﬁnd new information embedded
in documents [5]. Craven and Kumlien [5] identiﬁed that
the information extraction task may include sub-cellu-
lar/cell localization of proteins, tissue localization of
proteins, and drug interactions with a given protein.
Similar information extraction works have been ex-
plored in this domain. Named entities, such as protein
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on, have also been recognized [6–14]. Some of them have
used machine learning methods, e.g., Hidden Markov
Models (HMMs), and Support Vector Machines
(SVMs), to recognize protein/gene names [6,8,10,12–
14]. Others have used knowledge-based rules, accompa-
nied by lexical or morphological analysis, to help with
protein/gene name detection [7,9,11]. The relationships
between these entities, e.g., protein–protein, gene–gene,
drug–gene, drug–disease, etc., have also been extracted
[12,15–25]. EDGAR [12] used a POS tagger, NLP tech-
niques, other knowledge sources, and contextual rules to
identify the relationships between genes and drugs in
cancer therapy. Meanwhile, Adamic et al. [15] used a
statistical method to identify gene–disease connections
from literature. Protein/gene interactions have been dis-
covered automatically in the literature by methods that
utilized natural language processing, parsing techniques
or the analysis of sentences that discussed interactions
by using frequency analysis of individual words
[16,17,20–23,25]. Other relationships were extracted to
improve the performance of named entity recognition,
e.g., through the information supplied from protein/
gene keywords [18,19] or the Naı¨ve Bayes classiﬁer [24].
Named entity recognition is a fundamental step for
mining knowledge from biological articles. After identi-
fying named entities, most research [16,21–23,26] has
been based on some special verbs and their related noun
forms to discover molecular pathways or relationships.
These pre-speciﬁed words indicate actions associated
with protein or gene interactions. Blaschke et al. [16]
used 14 keywords for protein–protein interactions from
MEDLINE articles. Ng et al. [21] applied some function
words for the inhibit–activate relationships. Sekimizu
et al. [26] extracted gene relations associated with seven
frequently used verbs found in MEDLINE abstracts. In
all these papers, with the exception of Sekimizu, the key-
words are listed by intuition. Some keywords are com-
mon to most of the papers, while some are special.
The problem with the above approaches is that we can-
not be sure if the keyword set is complete for mining
biological relationships. This motivated us to ﬁnd bio-
logical keywords in an automatic way.
Collocation denotes two or more words that have
strong relationships [27]. For example, if the phrase
‘‘NF-kappa B activation’’ often appears in a sentence
where ‘‘NF-kappa B’’ is a protein name, it means that
‘‘NF-kappa B’’ and ‘‘activation’’ are collocations, i.e.,
‘‘NF-kappa B’’ and ‘‘activation’’ occur together in the
document. The related technologies have been applied
to terminological extraction, natural language genera-
tion, parsing, and so on. This paper deals with two spe-
cial collocations in the biological domain—namely:
protein collocation and gene collocation. We will deter-
mine those keywords that co-occur with protein or gene
names by using statistical methods. Such terms, referredto as collocates of proteins or genes hereafter, will be con-
sidered as restrictions in protein/gene name extraction.
In the former example of ‘‘NF-kappa B activation,’’
‘‘activation’’ is the collocate of the protein ‘‘NF-kappa
B.’’ Improving the precision rate, without substantially
lowering the recall rate is the primary goal of this ap-
proach. Furthermore, how to improve the recall rate at
a small expense to the precision rate is another interest-
ing topic. We will explore this issue by introducing an
integration of multiple name recognizers. In summary,
the motivation of this paper is to increase the perfor-
mance of existing molecular name detectors. The meth-
ods we adopted will be explained in Sections 3–5.
The rest of this paper is organized as follows. The
protein and the gene name recognizers used in this study
are introduced in Section 2. The collocation method we
adopted is described in Section 3. The ﬁltering and the
integration strategies are proposed in Sections 4 and 5,
respectively and the experimental results of these two
strategies are shown and discussed. Finally, in Section
6, we present our conclusions and suggest the direction
of future research.2. Molecular name recognizers
The detection of molecular names such as proteins and
genes presents a challenging task due to their variant
structural characteristics, their resemblance to regular
noun phrases and their similarity to other kinds of biolog-
ical substances. Many irregularities and ambiguities exist
in gene and protein nomenclature. For example, protein/
gene names may be synonymous with common words,
such as ‘‘ran,’’ ‘‘envelope,’’ ‘‘cat,’’ etc. In addition, some
principles of the nomenclature are similar to chemicals,
e.g., ‘‘Ca2+-ATPase’’ is a protein while ‘‘Ca2+’’ is a
chemical. Consequently, several issues have to be ad-
dressed during protein/gene name recognition.
Previous approaches to biological named entity
extraction can be classiﬁed in two types—namely: rule-
based [7,11,13,28,29] and corpus-based [6]. KeX devel-
oped by Fukuda et al. [7] and Yapex developed by
Olsson et al. [11] were based on handcrafted rules for
extracting protein names. Kex used surface clues like
upper case letters, numerical letters, and symbols to ex-
tract core terms and later connected them to other terms
in the surrounding text [7]. Yapex ﬁrst implemented
some heuristic steps described by Fukuda et al. [7],
and then applied ﬁlters and knowledge bases to remove
false hits. Finally, Yapex utilized the syntactic informa-
tion from the parser to identify protein names.
ABGene developed by Tanabe et al. [13] used Brills
tagger [30] as the fundamental extraction program, fol-
lowed by additional layers of post-processing rules to ﬁl-
ter out false positives, as well as to recover false
negatives in the ﬁrst-step tagging of gene and protein
Fig. 1. Flow of mining protein/gene collocates.
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words. For example, for the title ‘‘Genetic characteriza-
tion in two Chinese women,’’ Brills tagger will produce
the tagged result ‘‘Genetic/JJ characterization/NN in/IN
two/CD Chinese/JJ women/NNS’’ to indicate ‘‘Genetic’’
as an adjective, ‘‘characterization’’ as a common noun,
‘‘in’’ as a preposition, ‘‘two’’ as a cardinal number,
‘‘Chinese’’ as an adjective and ‘‘women’’ as a plural
common noun. Since gene names are usually single
nouns or noun phrases, it is helpful to recognize gene
names by applying Brills tagger. After tagging, the
post-processing rules are used to ﬁlter out false positives
and recover false negatives. For ﬁltering false positives,
on the one hand, ABGene precompiles some general
biological terms (acids, antigen, etc.,), amino acid
names, restriction enzymes, cell lines, and organism
names. On the other hand, ABGene uses regular expres-
sions to indicate that a word is not a gene name, e.g.,
common drug suﬃxes (-ole, -ane, -ate, etc.). For recov-
ering false negatives, ABGene applies contextual rules to
ﬁnd compound names. For example, one rule is ‘‘ANY-
GENE CC x,’’ where ‘‘ANYGENE’’ is a tagged gene,
‘‘CC’’ is a coordinating conjunction and ‘‘x’’ is the cur-
rent word. The constraint of this rule is that ‘‘x’’ con-
tains a capital letter, dash or number, and is not a
verb or an adverb. If matched, the tag of ‘‘x’’ will be
changed to CONTEXTGENE. Finally, compound
names are found. Some examples of ﬁltering out false
positives and recovering false negatives are described
in [13]. Idgene developed by Fan [29] is a dictionary-
based gene name identiﬁcation program. The basic idea
of Idgene is to use exact match for gene symbols and
fuzzy match for gene names/phenotypes, which gives a
suggestion list of the hit genes weighted by surrounding
contexts. Idgene also uses Brills tagger to get POS tags,
and then computes the scores of the exact/fuzzy
matches. Finally, Idgene merges shorter terms with
longer terms to obtain the ﬁnal scores. Both ABGene
and Idgene utilize some hand-made rules for extracting
gene names. Collier et al. [6] adopted a machine learning
approach that involved training a Hidden Markov
Model with a small corpus of 100 MEDLINE abstracts
to extract the names of gene and gene products.
Diﬀerent taggers have their own speciﬁc features. Id-
gene was evaluated on 156 Chinese Gene Variation pa-
pers selected from 1997 to 1998 BIOSIS Previews and
EMBASE [31]. It had a 24.68% precision rate and an
85.39% recall rate. ABGene was developed as a gener-
al-purpose gene tagger. Fan [29] applied ABGene to
the same test collection as the one used in Idgene. AB-
Gene achieved a 31.32% precision rate and an 81.46%
recall rate. KeX was evaluated by using 30 abstracts of
SH3 domain and 50 abstracts of signal transduction.
It achieved a 94.70% precision rate and a 98.84% recall
rate. Yapex was applied to a test corpus of 101 MED-
LINE abstracts. Of these, 48 documents were obtainedfrom queries about protein binding and interaction,
and 53 documents were randomly chosen from the
GENIA corpus [32]. The query posed to MEDLINE
was ‘‘protein binding [Mesh term] AND interaction
AND molecular’’ with the parameters abstract, English,
human, publication date 1996–2001. The performance of
tagging protein names was 70.90% for precision and
69.53% for recall. When the same test corpus was ap-
plied to KeX, it achieved a 40.41% precision rate and
a 41.13% recall rate. These results show that each tagger
has its own characteristics and changing the domain
may result in the variant performances. Therefore,
how to select the correct molecular entities proposed
by the existing taggers is an interesting issue.3. Statistical methods for collocation
The overall ﬂow of our method is shown in Fig. 1. To
extract protein/gene collocates, we need a corpus in
which protein/gene names have been tagged. Preparing
a tagged biological corpus is the ﬁrst step, after which
common stopwords are removed and stemming (e.g.,
map ‘‘listed’’ and ‘‘listing’’ to its root form ‘‘list’’) is ap-
plied to gather and group more informative words. The
collocation values of the proteins/genes and surrounding
words are then calculated. Finally, these values are em-
ployed to determine which neighbouring words are the
desired collocates. The major modules are speciﬁed in
detail in the following subsections.
3.1. Step 1: Tagging the corpus
To calculate the collocation values of words with
proteins/genes from a corpus, it is ﬁrst necessary to
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this paper deals with the performance issue of protein/
gene name tagging. Hence, preparing a protein/gene
name tagged corpus and developing high performance
protein/gene name taggers seem to be a chicken-and-
egg problem. Because the corpus developed in the ﬁrst
step is used to extract the contextual information of pro-
teins/genes, a completely tagged corpus is not necessary
at the ﬁrst step. A dictionary-based approach for molec-
ular name tagging, i.e., full pattern matching between
the dictionary entries and the words in the corpus, is
simple. The major problem is its coverage. Those pro-
tein/gene names that are not listed in the dictionary,
but appear in the corpus will not be recognized. Thus,
this approach only produces a partially tagged corpus,
which is suﬃcient to acquire contextual information
for use later in this research.
3.2. Step 2: Preprocessing
3.2.1. Step 2.1: Exclusion of stopwords
Stopwords are common English words (such as the
preposition ‘‘in’’ and the article ‘‘the’’) that frequently
appear in the text, but are not helpful in discriminating
special classes. Because they are distributed throughout
the corpus, they should be ﬁltered out to remove their
unnecessary impact in the text. The stopword list in this
study was collected with reference to the stoplists of Fox
[33], but words that also appeared in the protein/gene
lexicon have been removed from the stoplist. For exam-
ple, ‘‘of’’ is a constituent of the gene name ‘‘translocase
of inner mitochondrial membrane 8 homolog A,’’ so
‘‘of’’ is excluded from the stoplist. The major reason
for excluding such stopwords from the Fox list is to en-
able exact pattern matching with protein/gene names.
Finally, 387 stopwords were used.
3.2.2. Step 2.2: Stemming
Stemming is the procedure of transforming a word
from an inﬂected form to its root form. For example,
‘‘suggested’’ and ‘‘suggestion’’ will be mapped into the
root form ‘‘suggest’’ after stemming. The procedure
can group the words with the same semantics and there-
fore reﬂect more information around the proteins/genes.
3.3. Step 3: Computing collocation statistics
Pearson [34] has discussed problems of gene nomen-
clature in detail. The irregularity and the ambiguities
in gene and protein nomenclature make name identiﬁca-
tion more diﬃcult. From one MEDLINE abstract, we
have the following title: ‘‘The relationship between
Ca2+-ATPase and freely exchangeable Ca2+ in the
dense tubules: a study in platelets from women.’’ In this
example ‘‘Ca2+-ATPase’’ is a protein, while ‘‘Ca2+’’ is a
chemical. However, they are both composed of lettersplus numbers and symbols. Obviously, the nomencla-
ture rules are irregular, so we must ﬁnd other clues to
help name recognition. The clues here are in the context.
For ‘‘Ca2+-ATPase,’’ the context is ‘‘The relationship
between’’ and ‘‘and freely exchangeable Ca2+ in’’ if
we take the three words before, and the ﬁve words after
it. For ‘‘Ca2+,’’ its context is ‘‘between Ca2+-ATPase
and freely exchangeable’’ and ‘‘in the dense tubules:
a.’’ If we know the protein collocates contain ‘‘relation-
ship,’’ we can pick ‘‘Ca2+-ATPase’’ as a protein and dis-
card ‘‘Ca2+.’’ In such a way, a collocate of protein/gene
can help to improve precision. This section proposes
three collocation statistics to ﬁnd the collocates of pro-
teins/genes, which often co-occur with protein/gene
names in the corpora.
3.3.1. Frequency
The ﬁrst statistical method we used in this study was
frequency. In this phase, the collocates were selected by
frequency. To gather more ﬂexible relationships, we de-
ﬁned a collocation window that has ﬁve words on each
side of protein/gene names. Then, collocation bigrams
at a distance were captured. In general, more occur-
rences in the collocation windows are preferred, but
the standard criteria for frequencies are not acknowl-
edged. For example, ‘‘go’’ occurs in the protein colloca-
tion window 14 times, and ‘‘pathway’’ occurs in the gene
collocation windows nine times. How to decide if ‘‘go’’
is a good protein collocate, while ‘‘pathway’’ is not a
good gene collocate is a diﬃcult issue. Hence, other col-
location models are also considered.
3.3.2. Mean and variance
The second statistical method we applied was mean
and variance. The mean value of collocations can indi-
cate how far collocates are typically located from pro-
tein/gene names. Furthermore, this method shows the
deviation from the mean. The standard deviation of va-
lue zero indicates that the collocates and the protein/
gene names always occur at exactly the same distance
equal to the mean value. If the standard deviation is
low, two words usually occur at about the same dis-
tance, i.e., near the mean value. If the standard devia-
tion is high, then the collocates and the protein/gene
names usually occur at random distances.
We used the following formulas to calculate mean
and standard deviations, respectively.
di ¼
Pn counti
j¼1 dij
n counti
; ð1Þ
si ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃPn counti
j¼1 ðdij  diÞ2
n counti  1
s
; ð2Þ
where di is the average distance for word i in the collo-
cation windows. dij is the distance of the jth occurrence
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windows. For example, dij = 1 means the jth occur-
rence of word i is located directly to the left of the pro-
teins/genes in the collocation window. n_counti is the
total number of occurrences of word i in the document
set. si is the standard deviation of dij.
The following examples illustrate the meaning of
mean and variance for the word ‘‘activation’’ and
proteins.
(1) IL-2 gene expression and <prot>NF-kappa B
</prot> activation through <prot>CD28</prot> requires
rea ctive oxygen production by <prot>5-lipoxygenase
</prot>.
(2) Activation of the <prot>CD28 surface receptor
</prot> provides a major costimulatory signal for T cell
activation.
In Sentence (1), activation occurs directly on the right
of NF-kappa B and on the left 2nd position away from
CD28. In Sentence (2), ‘‘activation’’ occurs on the left
3rd position away from CD28 surface receptor. Thus,
the average distance for activation is (1 + (2) + (3))/
3. The result is 1.33, and the standard deviation is
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
ð1 ð1:33ÞÞ2 þ ð2 ð1:33ÞÞ2 þ ð3 ð1:33ÞÞ2
3 1
s
:
The value of the standard deviation is equal to 1.472
which means that activation may occur on the left or
right at a distance of 1.472 words away from the average
distance, which is 1.33 in this example.Table 1
Examples of protein collocates
Bind Active Determine Regulate Involve
Reﬁne Resolve Find Express Recognize
Inhibit Catalyze Reveal Increase Detect
React Control Study Contain Result
Table 2
Examples of gene collocates
Active Specify Express Mediate Increase
Associate Inhibit Resist Bind Concentrate
Regulate Response Study Suggest Stimulate
Treat Result Release Depend Decrease3.3.3. t test model
When the values ofmean and variance are computed, it
is necessary to know that two words do not co-occur by
chance. We also need to know if the standard deviation
is low enough. In other words, we have to set a threshold
in the above approach. To achieve the statistical conﬁ-
dence that two words have a collocation relationship, a
hypothesis testing, t test, is adopted.
Consider a document set with total n words. The t
value for each word i, ti, is formulated as follows:
ti ¼ xi  uiﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
s2i =N
p ;
where N is the total word frequencies in the window,
xi ¼ n counti=N , s2i ¼ pi  ð1 piÞ, pi = n_counti/n,
ui = pprotein/gene · pi, and pprotein/gene is the probability of
protein/gene.
The conﬁdence level, i.e., a, is a statistical calculation
that measures the degree of certainty (or likelihood) of a
correlation, result or forecast. When a is equal to 0.005,
the value of t is 2.576. In the t test model, if the t value islarger than 2.576, the word is regarded as a good collocate
of a protein/gene with 99.5% conﬁdence.
3.4. Step 4: Extraction of collocates
MEDLINE is a massive biomedical corpus for infor-
mation retrieval, information extraction and knowledge
discovery. Biomedical experts often explore new devel-
opments in special topics by retrieving relevant docu-
ments from MEDLINE. To preserve the independence
between proteins and genes, we used diﬀerent document
sets as training corpora for proteins and genes in this
extraction phase.
In the experiments for proteins, the documents used
in TREC 2003 Genome Track [35] were considered as
the training corpus. The text collection consists of
525,936 MEDLINE abstracts where indexing was com-
pleted between 4/1/2002 and 4/1/2003. We applied the
procedures Steps 1–3 mentioned in this section to this
data collection. There are 57,307 protein collocations
generated in Step 3. The collocates are not ﬁltered out
by part of speech, so the output may contain nouns,
prepositions, numbers, verbs, etc.
In the experiments for genes, the documents gathered
from the LocusLink database [36] (http://www.ncbi.nlm.
nih.gov/LocusLink) were adopted as the training corpus.
The text collection consists of 30,936 MEDLINE ab-
stracts. Applying Steps 1–3 in Section 3 to this document
collection, we obtained 14,150 gene collocations.
The collocates extracted from a corpus not only serve
as conditions of protein or gene names, but also facili-
tate the discovery of the relationship between proteins
(genes) [18]. Verbs are the major targets in the extraction
of biological information, (such as Blaschke et al. [16],
Ng et al. [21], and Ono et al. [37], etc.). This is because
the subjects and the objects related to these verbs tend to
be names of proteins or genes. To ensure that the collo-
cates selected in Step 3 were verbs, we assigned part of
speech to these words. There are 12,826 protein collo-
cates and 3,541 gene collocates. Examples of protein
and gene collocates are listed in Tables 1 and 2.
W.-J. Hou, H.-H. Chen / Journal of Biomedical Informatics 37 (2004) 448–460 4534. Consideration of precision rate
4.1. Filtering strategies
For protein/gene name recognition, rule-based sys-
tems and dictionary-based systems are usually comple-
mentary. Rule-based systems can recognize those
protein/gene names not listed in a dictionary, but some
false entities may also pass at the same time. For exam-
ple, both ‘‘HCMV’’ and ‘‘NFAT’’ are composed of cap-
ital letters. However, ‘‘HCMV’’ is a virus that may be
recognized as protein/gene, whereas ‘‘NFAT’’ is deﬁ-
nitely a protein. Other examples are ‘‘BL-2,’’ a cell line
which may be tagged as a protein/gene name, and
‘‘AP-2,’’ which is a protein. Dictionary-based systems
can recognize molecular entities in a dictionary, but
the coverage of all proteins/genes is a major deﬁciency.
A challenge is how to use dictionary information to cor-
rectly identify molecular entities. In this section, we em-
ploy collocates of proteins/genes mined earlier to help
identify the molecular entities. The Yapex system [11]
and ABGene [13] are adopted to propose candidates,
and protein/gene collocates serve as restrictions to ﬁlter
out less likely protein/gene names.
The following ﬁltering strategies are proposed. We ex-
plain them from a protein viewpoint. Let us assume that
the candidate set M0 is the output generated by Yapex.
 M1: For each candidate in M0, we will check if a col-
locate is found in its collocation window. If it is, we
will tag the candidate as a protein name. Otherwise,
we will discard it. For example, in the sentence IL-2
gene expression and NF-kappa B activation through
CD28 requires reactive oxygen production by 5-lipoxy-
genase., Yapex tagged ‘‘IL-2,’’ ‘‘CD28,’’ and ‘‘5-li-
poxygenase’’ as proteins. If ‘‘activation’’ and
‘‘reactive’’ are protein collocates, then ‘‘CD28’’ and
‘‘5-lipoxygenase’’ will be retained, since ‘‘activation’’
and ‘‘reactive’’ occur in the collocation window of
‘‘CD28’’ and ‘‘reactive’’ occurs in the collocation win-
dow of ‘‘5-lipoxygenase.’’
 M2: Some of the collocates may be substrings of pro-
tein names. We relax the restriction in M1 as follows:
If a collocate appears in the candidate, or in the collo-
cation window of the candidate, then we tag the can-
didate as a protein name; otherwise, we discard it. For
example, in the sentence: . . ., since FGF-1 -induced Rel/
kappa B binding proteins do not contain signiﬁcant lev-
els of c-Rel and are not identical with the CD28
response complex, ‘‘FGF-1’’ and ‘‘Rel/kappa B bind-
ing proteins’’ are protein names. ‘‘FGF-1’’ can be
retained with strategy M1, while ‘‘Rel/kappa B bind-
ing proteins’’ cannot because the protein collocate
‘‘binding’’ is located in the window of ‘‘FGF-1’’ and
not in the window of ‘‘Rel/kappa B binding proteins.’’
If we apply strategy M2, the latter will be found. M3: Some protein names may appear more than once
in a document. They may not always co-occur with
some collocates in each occurrence. In other words,
the protein candidate and some collocates may co-oc-
cur in the ﬁrst, the second, or even the last occur-
rence. To resolve this problem, we revise M1 and
M2 as follows. If there exists a collocate co-occurring
with a protein candidate during checking, the candi-
date without any collocate is kept undecided instead
of being discarded. After all the protein names have
been examined, those undecided candidates may be
considered as protein names if one of their co-occur-
rences contains any collocate. In other words, as long
as a candidate has been conﬁrmed once, it is assumed
to be a protein throughout. In this way, there are two
ﬁltering alternatives M31 and M32 from M1 and M2,
respectively. For example, in the sentence: ‘‘Full acti-
vation of the MAP kinases that phosphorylate the
Jun activation domain, JNK1 and JNK2, required
costimulation of T cells with either TPA and Ca2+
ionophore or antibodies to TCR and CD28,’’ there
are no protein collocates around ‘‘CD28.’’ If we
apply strategy M31, ‘‘CD28’’ will be retained as a
protein because it has been collocated with protein
collocates from other parts of the documents. The
example for strategy M32 is the same with the one
illustrated for strategy M31. Although there are no
protein collocates around proteins ‘‘the Jun activa-
tion domain’’ and ‘‘CD28,’’ strategy M32 helps rec-
ognize them as follows. First, ‘‘the Jun activation
domain’’ will be detected because a collocate ‘‘activa-
tion’’ appears in the protein name ‘‘the Jun activation
domain’’. Furthermore, ‘‘CD28’’ will be retained as a
protein because it has been collocated with protein
collocates from other parts of the documents.4.2. Evaluation of ﬁltering strategies
To get an additional objective evaluation, we utilized
another corpus of 101 abstracts used by Yapex [http://
www.sics.se/humle/projects/prothalt] for protein extrac-
tion. Similarly, we used the GENIA corpus version
3.02 [38] of 2000 abstracts for the gene evaluations.
Using the test corpora and answer keys provided in
the Yapex project and the GENIA project, the evalua-
tion results of ﬁltering strategies for proteins and genes
are listed in Tables 3 and 4, respectively. Note that the
baseline model M0 was not applied during the ﬁltering
strategies.
We can partition the labelled results into four groups:
True Positives (TP): items correctly labelled as positive;
False Positives (FP): items incorrectly labelled as positive;
TrueNegatives (TN): items correctly labelled as negative;
False Negatives (FN): items incorrectly labelled as
negatives.
Table 4
Gene evaluation on ﬁltering strategies
Precision (%) Recall (%) F-score (%)
M0 55.87 74.56 65.22
M1 65.93 69.50 67.72
M2 69.26 69.89 69.58
M31 69.79 71.46 70.63
M32 70.08 71.89 70.99
Table 3
Protein evaluation on ﬁltering strategies
Precision (%) Recall (%) F-score (%)
M0 70.90 69.53 70.22
M1 82.10 57.42 69.76
M2 82.35 57.96 70.16
M31 85.89 66.48 76.19
M32 85.84 67.09 76.47
454 W.-J. Hou, H.-H. Chen / Journal of Biomedical Informatics 37 (2004) 448–460In Table 3, precision, recall, and F-score are calcu-
lated according to the following equations:
Precision ðPÞ ¼ TP
TPþ FP ;
Recall ðRÞ ¼ TP
TPþ FN ; and
F -score ¼ 2PR
P þ R :
Compared with the baseline model M0 in Table 3, the
precision rates of all the four models using protein col-
locates improved more than 11.20%. The recall rates
of M1 and M2 decreased 12.11 and 11.57%, respectively.
Thus, the overall F-scores of M1 and M2 decreased 0.46
and 0.06%, compared to M0. In contrast, if the decision
of tagging was deferred until all the information was
considered, the recall rates only decreased by 3.05 and
2.44%, and the F-scores of M31 and M32 increased
5.97 and 6.25% relative to M0. The best strategy,
M32, improved the precision rate from 70.90 to
85.84%, and the F-score from 70.22 to 76.47%.
In Table 4, the precision rates of all the four models
using gene collocates were improved more than 10.06%.
The recall rates of M1 and M2 decreased 5.06 and
4.67%, respectively. Thus, the overall F-scores of M1
and M2 increased 2.50 and 4.36%, compared to M0. If
the decision of tagging was deferred until all the informa-
tion was considered, the recall rates only decreased by
3.10 and 2.67%, and the F-scores of M31 and M32 in-
creased by 5.41 and 5.77% relative to M0. The best one,
M32, improved the precision rate from 55.87 to 70.08%,
and the F-score from 65.22 to 70.99%. Compared to the
experimental results shown inTable 3, the same trends oc-
curred for genes shown in Table 4. The results meet our
expectations, i.e., to enhance the precision rate, without
signiﬁcantly reducing the recall rate.5. Consideration of the recall rate
5.1. Integration strategies
Here, we analyze the tagged results from protein/gene
taggers. There are four types of errors generated by the
taggers.
(1) Type 1: completely wrong labelling, e.g., ‘‘HCMV’’
may be tagged as a protein.
(2) Type 2: partially wrong labelling with some correct
components in the tagged results. This is due to a
mistake about the boundary. For example, ‘‘soluble
CD4-IgG’’ may be tagged as a protein rather than
the correct tagging ‘‘CD4-IgG.’’
(3) Type 3: incomplete labelling. For example, ‘‘NAFT
or AP-1 sites,’’ is an instance of a complete gene,
but it may be incompletely labelled as ‘‘NAFT or
AP-1.’’
(4) Type 4: missing labelling. This occurs when some
protein/gene names are not tagged. For example,
‘‘E2F-1’’ may be considered as a non-protein.
Using the ﬁltering strategies introduced in Section
4.1, the most helpful collocates were of Type 1. For
Types 2 and 3, the collocates help a little because they
may also appear in the collocation window of the wrong
labelled gene/protein names. To solve the errors of
Types 2 and 3, there is an additional requirement to
determine where the name begins and ends within a sen-
tence. Finally, our ﬁltering method cannot help with
Type 4, since we cannot produce untagged names.
To improve recall, we introduce integration strategies
based on a hybrid concept of two protein/gene name tag-
gers. By employing the integration strategies, we resolve
errors of Types 2 and 3 by employing integration strate-
gies. The basic idea is that diﬀerent protein/gene name tag-
gers have their own speciﬁc features such that they can
recognize diﬀerent sets of NEs according to their rules
or recognition methods. Among the proposed protein/
gene names provided by diﬀerent systems, there may exist
some overlaps and some diﬀerences. In other words, a
protein/gene name recognizer may tag a protein or gene
that another recognizer cannot identify, or both of them
may accept certain common molecular entities. The inte-
gration strategies are used to select correct protein/gene
names proposed by multiple recognizers. In this study,
we conducted several experiments for diﬀerent domains:
(1) For protein name recognition, Yapex and KeX are
adopted because they are freely available on the web; (2)
For gene name recognition, ABGene and Idgene are in-
cluded because the developers were kind enough to pro-
vide the resources for our experiments.
Because protein/gene candidates are proposed by two
named entity extractors independently, they may be
completely separate, completely the same, overlapped
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at the end. Fig. 2 shows these ﬁve cases.
For example, if there is a sentence as follows:
We have previously found a high expression of human
Ah receptor (TCDD receptor) mRNA in peripheral blood
cells of individuals.
If one systemonly taggedAh receptor as a protein name
and the other system proposed TCDD receptor as a pro-
tein name, then this sentence belongs to Type A: com-
pletely separate. If two systems all tagged TCDD
receptor as a protein name, this is a case of Type B: com-
pletely the same. If one system tagged human Ah receptor
as a protein name, while another tagged Ah receptor
(TCDD receptor) as a protein name, this is a case of Type
C: overlapped in between, where Ah receptor is the over-
lapped part. If one system taggedAh receptor as a protein
name and the other one proposed Ah receptor (TCDD
receptor) as a protein name, this is a case of TypeD: over-
lapped in the beginning where Ah receptor is the over-
lapped part.
For the last case: Type E, let us look at another
example:
Whereas diﬀerent anti-CD4 mAb or HIV-1 gp120
could all trigger activation of the protein tyrosine kinases
p56lck and p59fyn and phosphorylation of the Shc adaptor
protein, which mediates signals to Ras, they diﬀered sig-
niﬁcantly in their ability to activate NF-AT.
If one system recognized protein tyrosine kinases
p56lck as a protein name and the others recognizedFig. 2. Candidates proposed by two systems.p56lck as a protein name, we called this a Type E and
p56lck the overlapped part.
The integration strategies shown as follows combine
the results from two molecular named entity extractors.
 When the protein/gene names produced by two rec-
ognizers are completely separate (i.e., type A), we
retain each of them as the protein/gene candidates.
This integration strategy postulates that one protein
(or gene) name recognizer may extract some proteins
(or genes) that another recognizer cannot identify.
 When the protein/gene names proposed by two recog-
nizers are exactly the same (i.e., type B), we also
retain each of them as the protein/gene candidates.
The reason is that when both taggers accept the same
protein (or gene) names, there must be some special
features that the protein (or gene) names ﬁt.
 When the protein/gene names tagged by two taggers
have partial overlap (i.e., types C, D, and E), two
additional integration strategies are employed, i.e.,
Yapex-based and KeX-based strategies for proteins,
and AB-based and Id-based strategies for genes. In
the former strategy, we adopt protein/gene names
tagged by Yapex/ABGene as candidates and discard
the ones produced by KeX/Idgene. In contrast, the
names tagged by KeX/Idgene are kept in the latter
strategy. The integration strategy is used because
each recognizer has its own characteristics, and we
do not know, in advance, which one will perform bet-
ter. Therefore, we consider one of them as a basis,
and then introduce new contributions from another
recognizer. That is, if KeX serves as a basis, we
choose the tagged names by KeX if any overlaps exist
between KeX and Yapex.5.2. Integration evaluation of proteins
The integration strategies described in Section 5.1
bring together all the possible protein/gene candidates
except the ambiguous cases (i.e., types C, D, and E).
That tends to increase the recall rate. To avoid reducing
the precision rate, we also employed the protein/
gene collocates mentioned in Section 3 to ﬁlter out the
less likely protein/gene candidates. Furthermore, to
objectively evaluate the performance of the proposed
collocates, we applied our strategies to the test corpus
using the terms suggested by human experts on protein
evaluation. A total of 48 verbal protein keywords that
were used to ﬁnd the pathway of proteins are listed in
Appendix.
The following four sets of experiments were designed
for the Yapex- and KeX-based integration strategies.
(1) YA and KA: The possible protein candidates are
merged from the results of the Yapex and KeX sys-
tems. If there are any conﬂicts, the candidates are
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the protein collocates automatically extracted in Sec-
tion 3 to ﬁlter out the candidates described in Sec-
tion 4. That is, we check the co-occurrence of the
collocate and protein candidate, no matter which
type the protein candidate belongs to.
(2) YB and KB: In the second experiment, we use the
terms suggested by human experts for the ﬁltering
strategies. YB (KB) is similar to integration strategy
YA (KA), except that the collocates are terms sug-
gested by human experts, rather than terms
extracted in Section 3.
(3) YA-C and KA-C: If Yapex and KeX recommend
the same protein names (i.e., type B), we regard
them as protein names, without consideration of
the collocates. Otherwise, we use the protein collo-
cates proposed in this study to do the ﬁltering.
(4) YB-C and KB-C: The method is similar to (3) except
that the protein collocates are replaced by the terms
suggested by human experts.
The experimental results for Yapex-based and KeX-
based integration are listed in Tables 5 and 6, respec-
tively. M0 is the baseline model. The named entities
proposed by M0 are combined from the results of Yapex
and KeX without ﬁltering (i.e., without collocate check-Table 5
Evaluation results on Yapex-based integration strategy
YA Precision (%) Recall (%) F-score (%)
M0 61.98 77.52 69.75
M1 73.56 71.95 72.76
M2 74.98 72.21 73.60
M31 78.84 75.37 79.11
M32 78.81 76.24 77.53
YB
M1 66.79 44.30 55.55
M2 66.79 44.81 55.80
M31 70.20 65.06 67.63
M32 70.19 65.51 67.85
Table 6
Evaluation results on KeX-based integration strategy
KA Precision (%) Recall (%) F-score (%)
M0 60.43 70.60 65.52
M1 66.93 57.48 62.21
M2 66.54 58.36 62.45
M31 67.89 66.79 67.34
M32 67.63 67.21 67.42
KB
M1 67.56 41.20 54.38
M2 66.99 41.71 54.35
M31 69.57 55.70 61.64
M32 69.25 56.26 62.76ing). M0 is used to evaluate the performance changes of
the following four cases: without ﬁltering, ﬁltering only,
integration only; and both ﬁltering and integration.
The tendencies M32 > M31 > M2 > M1 are still kept
in the new experiments. The strategy of delaying the
decision until clear evidence found is workable. The per-
formances of YA, YA-C, KA, and KA-C are better
than the performances of the corresponding models
(i.e., YB, YB-C, KB, and KB-C). This shows that the
set of collocates proposed by our system is more com-
plete than the set of terms suggested by human experts.
Compared with the recall rate of M0 in Table 3 (i.e.,
69.53%), the recall rates of both Yapex- and KeX-based
integration are increased, i.e., 77.52 and 70.60%, respec-
tively. This matches our expectations. However, Table 6
shows that the precision rates are reduced more than the
increase of the recall rates in some cases. The F-score of
KeX-based integration strategy in M1 model is 3.31%
worse than that of the baseline M0. This shows that
KeX did not perform well in this test set, because it can-
not recommend good candidates at the integration
stage. Moreover, Table 5 shows that the F-scores of
all YA and YA-C models are better than the corre-
sponding models in Table 3 where only the ﬁltering
strategies are used. This indicates that Yapex performed
better in this test corpus, so that we can enhance theYA-C Precision (%) Recall (%) F-score (%)
M1 73.83 74.18 74.01
M2 75.93 75.25 75.59
M31 79.42 76.43 77.93
M32 79.40 76.69 78.05
YB-C
M1 68.92 58.09 63.51
M2 68.78 58.49 63.64
M31 69.07 69.08 69.13
M32 69.07 69.63 69.35
KA-C Precision (%) Recall (%) F-score (%)
M1 67.83 64.28 66.06
M2 67.64 64.87 66.26
M31 66.93 67.92 67.43
M32 66.81 68.35 67.58
KB-C
M1 69.57 55.60 62.59
M2 69.15 56.10 64.06
M31 68.36 60.22 64.29
M32 68.09 60.78 64.44
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strategies. On the other hand, the F-scores of YB and
YB-C are worse than those of M0 in Table 3. This
shows that the set of terms suggested by human experts
is too weak to improve the performance in the integra-
tion strategies. Nevertheless, the models in Table 6 still
cannot compete with M32 in Table 3. The reason may
be that some heuristic rules used in Yapex are borrowed
from KeX (such as the use of feature terms, e.g., pro-
tein, particle, and receptor) [11], and added additional
ﬁltering strategies (e.g., ﬁltering out names of chemical
substances, bibliographical references, chemical formu-
las, etc.).
5.3. Integration evaluation of genes
We have shown the evaluation results using our inte-
gration strategies in the protein domain in Section 5.2.
A similar scheme can be applied to the gene domain.
Here, we employ the integration strategies to enlarge
the candidate sets, and the gene collocates mentioned in
Section 3 to ﬁlter out the less likely gene candidates. The
terms suggested by human experts are not as complete
as the ones our automated method produced. This is
demonstrated by the following two sentences.
The binding capacity and aﬃnity of the glucocorticoid
receptors were measured and compared to clinical data
and the plasma cortisol concentrations.
An over-representation of T2 in ovarian cancer patients
compared with controls in the pooled Irish/German pop-
ulation (P<0.025) was observed.
The protein glucocorticoid receptors and gene T2 are
collocated with ‘‘compared’’ which is missed by human
experts.Table 7
Evaluation results on AB-based integration strategy
AB Precision (%) Recall (%) F-score (%)
M0 54.29 84.47 69.38
M1 64.84 74.98 69.91
M2 65.15 75.46 70.31
M31 67.21 76.88 72.05
M32 68.35 77.33 72.84
Table 8
Evaluation results on Id-based integration strategy
ID Precision (%) Recall (%) F-score (%)
M0 31.79 75.22 53.51
M1 44.62 66.96 55.79
M2 45.03 67.53 56.28
M31 49.16 68.28 58.72
M32 49.74 69.04 59.39Since the terms suggested by human experts are not
as complete as the ones extracted from the corpus, we
did not conduct experiments on the terms suggested by
human experts in this section. In the following, two sets
of experiments for diﬀerent bases (i.e., ABGene and Id-
gene), called AB- and Id-based integration strategies,
respectively, are conducted.
(1) AB and ID: In these experiments, we use the gene
collocates automatically extracted in Section 3 to ﬁl-
ter out the candidates merged from the results of
ABGene and Idgene.
(2) AB-C and ID-C: If ABGene and Idgene recommend
the same gene names, we will select them without
consideration of gene collocates. Otherwise, we will
use the gene collocates proposed in this study to
do the ﬁltering.
The evaluation results of integration strategies on
gene domain are listed in Tables 7 and 8.
Some results are in agreement with those in the protein
experiments. First, the tendencies M32 > M31 > M2 >
M1 are still kept in the gene experiments. Second, the re-
call rates of all models in AB-based integration are in-
creased compared with the recall rate of M0 in Table 4.
Third, the results AB-C > AB and ID-C > ID are similar
to the results YA-C > YAandKA-C > KA.These results
demonstrate that (1) the strategy of delaying the decision
until clear evidence is found is useful, (2) the integration
strategy is workable for collecting additional correct
molecular entities, and (3) if two systems recommend
the same biological name, it is an important cue. We
now examine Tables 7 and 8 further. Table 7 shows that
the precision rates are decreased less than the increase
of the recall rates. In contrast, the precision rates areAB-C Precision (%) Recall (%) F-score (%)
M1 67.41 78.16 72.78
M2 67.92 78.85 73.39
M31 69.93 80.54 75.24
M32 69.99 80.81 75.40
ID-C Precision (%) Recall (%) F-score (%)
M1 46.31 68.71 57.51
M2 47.29 69.23 58.26
M31 50.44 70.04 60.24
M32 51.71 70.82 61.27
Table 9
Summary of experimental results
Performance of protein/gene Strategy
Filtering +Filtering Filtering +Filtering
Integration Integration +Integration +Integration
Protein Precision 70.90 85.84 61.98 79.40
Recall 69.53 67.09 77.52 76.69
F-Score 70.22 76.47 69.75 78.05
Gene Precision 55.87 70.08 54.29 69.99
Recall 74.56 71.89 84.47 80.81
F-Score 65.22 70.99 69.38 75.40
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in Table 8. Idgene-based strategies cannot compete with
the M32 strategy in Table 4. This means that the AB-
based integration strategy performed well in this test set,
but the Id-based integration strategy did not achieve a
good performance. In other words, ABGene performed
better in this test set than Idgene. Consequently, we infer
that ABGene recommended more good candidates than
Idgene. The reasonmay be that ABGene is a general-pur-
pose gene recognizer [13] and Idgene focuses on Chinese
Gene Variation [28]. Meanwhile, the test set, i.e., the
GENIA corpus, covers general documents, rather than
documents in some speciﬁc topic like Chinese Gene Var-
iation. This leads to the decreased performance of Idgene,
which is worse than ABGene.6. Concluding remarks
Table 9 summarizes the results of this paper. We pro-
pose a fully automatic method of mining collocates from
scientiﬁc texts in the protein and gene domains, and em-
ploy the extracted collocates to improve the precision
rate of protein/gene name recognition. The precision
of Yapex is increased from 70.90 to 85.84% at a small
expense in the recall rate (i.e., it only decreases 2.44%)
when collocates are incorporated. When the integra-
tion-only approach is adopted (i.e., ﬁltering, +integra-
tion), the F-score of the Yapex-based (ABGene-based)
integration is a little lower than that of the ﬁltering-only
approach (i.e., +ﬁltering, integration). This shows that
collocation learning is useful, and integration depends
on the individual performance NE recognizers. When
both ﬁltering and integration (i.e., +ﬁltering, +integra-
tion) strategies are employed together, the Yapex-based
integration with KeX achieves 7.83% F-score increase
compared to the pure Yapex method (i.e., ﬁltering,
integration). The ABGene-based integration with Id-
gene shows a 10.18% F-score increase relative to the
pure ABGene method.
The main beneﬁts of our method are: (1) The collo-
cates used in the ﬁltering strategies are produced by
the training corpus rather than by intuition. This formsa more complete set than one identiﬁed by human ex-
perts; (2) The combination of the ﬁltering and integra-
tion strategies shows better performance than the
original protein/gene name taggers. The main drawback
of our method is that we cannot solve the problem of
false negatives. To solve such problems, more linguistic
technologies need to be investigated in order to recover
the false negatives. In addition, the performance of
integrity strategies relied on the performance of the se-
lected taggers as shown in Table 9.
This tendency is consistent with gene and protein
name entity extraction. We expect that the methodolo-
gies can be easily extended to other domains, such as
drugs and diseases. This will be veriﬁed in future work.
The protein (or gene) collocates extracted from the do-
main corpus are also important keywords for pathway
discovery, so that a systematic way from basic named
entities ﬁnding to the discovery of complex relationships
can be explored. Although the relation extraction in-
volves more complex issues, such as related objects,
pathway direction and dependency relation, the correct
recognition of genome/protein is the most basic task
and this can be help with our methods. The values of
the frequency, average distance, standard deviation
and t-score can serve as some features for machine
learning approaches to tag the protein/gene names. This
will be studied. The experimental systems adopted in
this paper are rule-based. The eﬀects of combining dif-
ferent types of protein/gene name taggers, e.g., rule-
based and corpus-based, will be investigated in the
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control (-, -ed, -ing, -led, -ling, -s), cooperat (-e, -ed, -es, -ing, -ion, -or, -ors),correlat (-e, -ed, -es, -ing, -ion), coupl (-e, -ed, -es, -ing),crosslink (-, -ed, -ing, -s), deglycosylat (-e, -ed, -es, -ing, -ion, -ory),demethylat (-e, -ed, -es, -ing, -ion, -ory), dephosphorylat (-e, -ed, -es, -ing, -ion, -ory),eﬀect (-, -ed, -ing, -s), eliminat (-e, -ed, -es, -ing, -ion),enabl (-e, -ed, -es, -ing), enhanc (-e, -ed, -er, -es, -ing),glycosylat (-e, -ed, -es, -ing, -ion, -ory), group (-, -ed, -ing, -s),help (-, -ed, -ing, -s), hinder (-, -ed, -ing, -s),
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